Banned from the pharmaceutical business, Martin Shkreli says he's back in the drugs business — with a crypto twist

  • 📰 MarketWatch
  • ⏱ Reading Time:
  • 60 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 27%
  • Publisher: 97%

South Africa News News

South Africa South Africa Latest News,South Africa South Africa Headlines

Martin Shkreli says prison wasn't *that* bad as he charts a new crypto venture

The man known as the “Pharma Bro” and legally barred from the industry is seemingly back in the business.

Martin Shkreli, freed from prison earlier this year after serving most of a seven-year sentence for lying to investors, said he’s setting up a crypto company to make it easier to design and model compounds. In an interview with The Milk Road, a crypto newsletter, Shkreli said his idea isn’t just that would it replace expensive software, but also the computational power. The crypto element is his idea that people would be rewarded to share their computer power. “It’s a niche product for sure, but it could change the way medicine is made and help democratize this kind of fiefdom that’s the Pfizers, Mercks and Johnson & Johnson’s,” he said.

Shkreli also defended his price hike of Daraprim from $13.50 to $750 per pill. “The average cancer drug or rare disease drug in America in anywhere between $100,000 and $1 million. So I raised the price of Daraprim to something below, even though it’s a rare disease drug.” He differentiated his price rise from that of EpiPen.

“The companies that raised EpiPen’s price were Mylan and Pfizer, two really big companies. I ran a small, 100-person company in New York that we needed every dollar of revenue we can get.”

 

Thank you for your comment. Your comment will be published after being reviewed.
Please try again later.
We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

 /  🏆 3. in ZA

South Africa South Africa Latest News, South Africa South Africa Headlines